Related Experiment Video
Updated: Dec 29, 2025

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Morbihan Syndrome, a UK Case Series
Camille Yvon1, Hardeep Singh Mudhar2, Tessa Fayers3
1Sussex Eye Hospital, Brighton.
Morbihan syndrome, a rare facial swelling condition, presents unique diagnostic and treatment challenges. Effective interventions include oral isotretinoin, intralesional triamcinolone, and surgery for this chronic disorder.
Area of Science:
- Dermatology
- Ophthalmology
- Plastic Surgery
Background:
- Morbihan syndrome is a rare condition.
- Characterized by slow-onset erythema and solid edema of the upper face.
- Often presents with features suggestive of complicated rosacea and chronic lymphedema.
Purpose of the Study:
- To describe the clinical characteristics of 10 patients with Morbihan syndrome.
- To review the existing literature on this rare condition.
- To evaluate treatment outcomes for Morbihan syndrome.
Main Methods:
- Retrospective case series of 10 patients.
- Review of relevant medical literature.
- Diagnosis supported by lid biopsy.
Main Results:
- The majority of patients were male (80%) with a mean age of 67 years.
- 60% presented with asymmetrical disease, predominantly on the right side.
- Histological findings indicated inflammation and vascular dysfunction, consistent with rosacea and lymphedema.
- Oral isotretinoin, intralesional triamcinolone, and debulking surgery showed variable success.
Conclusions:
- Morbihan syndrome is a rare, chronic condition.
- Treatment can be challenging, often requiring a multimodal approach.
- Interventions like isotretinoin, steroid injections, and surgery offer potential management options.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
06:48Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Cystic Fibrosis: Management
Sinus disease and chronic...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...